🇺🇸 FDA
Patent

US 11623945

Immunostimulating compositions and uses therefore

granted A61KA61K2039/53A61K2039/552

Quick answer

US patent 11623945 (Immunostimulating compositions and uses therefore) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/53, A61K2039/552, A61K38/00, A61K39/0003